1010551001: Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)

\Medicinal product\Medicinal product categorized by disposition\Product containing Hepatitis C virus protein NS5B inhibitor (product)\Product containing sofosbuvir\Product containing sofosbuvir and velpatasvir\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing Hepatitis C virus protein NS5B inhibitor (product)\Product containing sofosbuvir\Product containing sofosbuvir and velpatasvir\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing Hepatitis C virus protein NS5B inhibitor (product)\Product containing sofosbuvir\Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing Hepatitis C virus protein NS5A inhibitor (product)\Product containing velpatasvir (medicinal product)\Product containing sofosbuvir and velpatasvir\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing Hepatitis C virus protein NS5A inhibitor (product)\Product containing velpatasvir (medicinal product)\Product containing sofosbuvir and velpatasvir\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing nucleotidyltransferase inhibitor\Product containing RNA polymerase inhibitor (product)\Product containing sofosbuvir\Product containing sofosbuvir and velpatasvir\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing nucleotidyltransferase inhibitor\Product containing RNA polymerase inhibitor (product)\Product containing sofosbuvir\Product containing sofosbuvir and velpatasvir\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing nucleotidyltransferase inhibitor\Product containing RNA polymerase inhibitor (product)\Product containing sofosbuvir\Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing velpatasvir (medicinal product)\Product containing sofosbuvir and velpatasvir\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing velpatasvir (medicinal product)\Product containing sofosbuvir and velpatasvir\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing sofosbuvir\Product containing sofosbuvir and velpatasvir\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing sofosbuvir\Product containing sofosbuvir and velpatasvir\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing sofosbuvir\Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing velpatasvir (medicinal product)\Product containing sofosbuvir and velpatasvir\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing velpatasvir (medicinal product)\Product containing sofosbuvir and velpatasvir\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing velpatasvir (medicinal product)\Product containing sofosbuvir and velpatasvir\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing velpatasvir (medicinal product)\Product containing sofosbuvir and velpatasvir\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing sofosbuvir\Product containing sofosbuvir and velpatasvir\Sofosbuvir + Velpatasvir\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing sofosbuvir\Product containing sofosbuvir and velpatasvir\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing sofosbuvir\Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Product manufactured as oral dose form\Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)\Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

4213153015 Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

4213154014 Sofosbuvir 200 mg and velpatasvir 50 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	Antiviral therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	Tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	200	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	Sofosbuvir	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Sofosbuvir	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	50	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Velpatasvir	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	Velpatasvir	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4213153015	Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
4213154014	Sofosbuvir 200 mg and velpatasvir 50 mg oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module